NF symposium to focus on tumor disorders
The School of Medicine is home to an internationally renowned center for multidisciplinary research of neurofibromatosis and comprehensive care of patients affected by it. The university’s Neurofibromatosis Center will host a symposium May 16 that will bring together patients, their family members and researchers to discuss the latest insight into the diagnosis and treatment of NF.
Reasons for learning problems tied to tumor disorder are complex
The causes of learning problems associated with an
inherited brain tumor disorder are much more complex than scientists had
anticipated, researchers at Washington University School of Medicine in
St. Louis report.
Study offers clues to cause of kids’ brain tumors
Insights from a genetic condition that causes brain
cancer are helping scientists better understand the most common type of
brain tumor in children.
Pediatric tumors traced to stem cells in developing brain
Stem cells that come from a specific part of the developing brain help fuel the growth of brain tumors caused by an inherited condition, researchers, including David H. Gutmann, MD, PhD, at Washington University School of Medicine in St. Louis report.
Gutmann recognized for neurofibromatosis research
David H. Gutmann, MD, PhD, a neurofibromatosis expert
at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington
University School of Medicine in St. Louis, has received the 2012
Friedrich von Recklinghausen Award.
WUSTL Neurofibromatosis Center to host symposium May 4
The Washington University Neurofibromatosis (NF) Center
at will host its first research symposium May 4. The event will
focus on clinical and basic science research on neurofibromatosis 1, an inherited condition that increases risk of brain tumors in children and adults.
Finding may help prevent vision loss in tumor disorder
Nerve cells in the body and brain react in opposite ways to the loss of a protein linked to a childhood tumor syndrome, researchers at Washington University School of Medicine in St. Louis have found. The finding could be important to efforts to preserve the vision of patients with neurofibromatosis 1, a genetic condition that increases risk of benign and malignant brain tumors.